Electromed, Inc. (AMEX:ELMD) Q4 2023 Earnings Call Transcript August 22, 2023 Operator: Greetings, and welcome to Electromed’s Fourth Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce Mike Cavanaugh, Investor Relations. […]
/PRNewswire/ - Microbion Corporation today announced that the company presented a poster highlighting the results from a series of in vitro and in vivo studies.
Inhaled colistimethate sodium showed a large benefit in one trial but produced almost no effect in the other, a result attributed to the COVID pandemic.
Patients with nontuberculous mycobacteria have more lung disease complications at baseline but their outcome at 5 years is almost same as that of patients with bronchiectasis alone.